The PNI, which combines serum albumin and the lymphocyte count has been demonstrated as a prognostic factor in several malignant tumors, including colorectal cancer, gastric cancer, malignant pleural mesothelioma, hepatocellular carcinoma, pancreatic cancer and small cell lung cancer [20–22, 26]. The gene discussed is ALB; the disease is colorectal cancer.